Yoozoo does not currently have any asset injection plans, Fenglong shares warn that the stock price has accumulated a significant trading risk.

On the morning of January 22nd, Fenglong Co., Ltd. replied to questions on the investor interactive platform, stating that within the next 36 months, Shenzhen Ubtech Robotics Corp., Ltd. has no plans or arrangements to go public through the restructuring of a listed company; in the next 12 months, Ubtech does not have any asset restructuring plans. As of now, Ubtech has no plans for asset injection, and the company's production and operation have not undergone significant changes, and there have been no major adjustments in market conditions or industry policies; it is expected that the company's main business will not undergo significant changes in the next 12 months. The company's stock price has risen sharply in the short term, accumulating huge trading risks, deviating significantly from market trends, and there may be a risk of rapid decline in the stock price in the future. Currently, the company's stock price has severely diverged from the company's fundamentals, and there are risks of overheated market sentiment and irrational speculation. If the company's stock price further abnormally rises in the future, the company may once again apply to the Shenzhen Stock Exchange for a trading halt for verification. Investors are reminded to invest rationally and pay attention to investment risks.